Colinz Laboratories - Quaterly Results

31 Jan 2024 Evaluate
The Total revenue for the quarter ended December 2023 of  Rs. 17.14 millions remain, more or less, the same.Profit after tax improved marginally to Rs. 1.05  millions for the quarter ended December 2023 from Rs. 1.04 millions of corresponding previous quarter.OP of the company witnessed a marginal growth to 1.88 millions from 1.80 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 17.14 16.80 2.02 53.99 54.35 -0.66 71.55 69.74 2.60
Other Income 0.48 0.43 11.63 1.68 1.29 30.23 1.72 1.71 0.58
PBIDT 1.88 1.80 4.44 5.85 5.79 1.04 7.80 7.57 3.04
Interest 0.10 0.14 -28.57 0.27 0.39 -30.77 0.52 0.76 -31.58
PBDT 1.78 1.66 7.23 5.58 5.40 3.33 7.28 6.81 6.90
Depreciation 0.33 0.32 3.13 0.99 0.96 3.13 1.29 2.01 -35.82
PBT 1.45 1.34 8.21 4.59 4.44 3.38 5.99 4.80 24.79
TAX 0.40 0.30 33.33 1.11 1.13 -1.77 1.43 1.41 1.42
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.16 -0.09 77.78
PAT 1.05 1.04 0.96 3.48 3.31 5.14 4.56 3.39 34.51
Equity 25.19 25.19 0.00 25.19 25.19 0.00 25.19 35.45 -28.94
PBIDTM(%) 10.97 10.71 2.37 10.84 10.65 1.71 10.90 10.85 0.43

Colinz Laboratories Share Price

71.71 1.24 (1.76%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.